Online citations, reference lists, and bibliographies.
← Back to Search

New Era Of Radiotherapy: An Update In Radiation-induced Lung Disease.

M. Benveniste, J. Welsh, M. Godoy, S. Betancourt, O. Mawlawi, R. Munden
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Over the last few decades, advances in radiotherapy (RT) technology have improved delivery of radiation therapy dramatically. Advances in treatment planning with the development of image-guided radiotherapy and in techniques such as proton therapy, allows the radiation therapist to direct high doses of radiation to the tumour. These advancements result in improved local regional control while reducing potentially damaging dosage to surrounding normal tissues. It is important for radiologists to be aware of the radiological findings from these advances in order to differentiate expected radiation-induced lung injury (RILD) from recurrence, infection, and other lung diseases. In order to understand these changes and correlate them with imaging, the radiologist should have access to the radiation therapy treatment plans.
This paper references
10.1177/153303460800700109
Advances in 4D Medical Imaging and 4D Radiation Therapy
G. Li (2008)
10.1016/J.IJROBP.2003.09.086
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
H. Murshed (2004)
10.1148/RADIOGRAPHICS.20.1.G00JA1167
Unusual radiologic findings in the thorax after radiation therapy.
B. Mesurolle (2000)
10.1016/S0360-3016(02)04150-0
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
Surgical therapy for carcinoma of the lung.
T. Shields (1993)
10.1016/0360-3016(94)00660-D
Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung.
Z. Liao (1995)
10.1016/J.IJROBP.2006.07.1337
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
S. Wang (2006)
10.1002/1097-0142(19950101)75:1+<370::AID-CNCR2820751319>3.0.CO;2-Q
Non‐Hodgkin's lymphoma
Timothy C. Greiner (1995)
10.2214/AJR.159.6.1442375
Radiation effects on the lung: clinical features, pathology, and imaging findings.
S. Davis (1992)
10.1002/1097-0142(19800601)45:11<2744::AID-CNCR2820451108>3.0.CO;2-U
A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non‐oat‐cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group
C. Perez (1980)
Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
M. Reinhardt (1997)
10.1159/0000106046
Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.
R. Timmerman (2007)
10.1016/j.clon.2010.03.010
Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
M. F. Hatton (2010)
10.3109/10428194.2010.493250
Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma
B. Hoppe (2010)
10.1016/j.radonc.2008.04.007
Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.
P. Mancosu (2008)
10.1016/S0360-3016(01)01772-2
Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
J. Bradley (2002)
10.1016/J.IJROBP.2006.04.015
Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
L. Fang (2006)
10.1016/S0140-6736(73)93260-1
Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up.
W. Fox (1973)
10.1002/1097-0142(19800215)45:4<698::AID-CNCR2820450414>3.0.CO;2-8
The role of curative radiotherapy in the treatment of lung cancer
P. Coy (1980)
10.1159/000262470
Altered fractionation schemes in radiotherapy.
M. Stuschke (2010)
10.1016/J.IJROBP.2006.07.147
116 : Radiation-Induced Esophageal Stricture Following Therapy for Lung Cancer: Its Clinical Course and Analysis Comparing Stricture Length With Isodose Levels
L. Marks (2006)
10.1016/j.radonc.2008.07.019
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
P. Baumann (2008)
10.1080/02841860600904854
Phase II study on stereotactic body radiotherapy of colorectal metastases
M. Høyer (2006)
10.2214/AJR.178.6.1781383
Radiation injury of the lung after three-dimensional conformal radiation therapy.
T. Koenig (2002)
10.1097/00004728-198204000-00003
CT Manifestations of Radiation‐Induced Change in Chest Tissue
J. Pagani (1982)
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for adiotherapy: An update in radiation-induced lung disease, Clinical M.F.K
M Feng (2009)
10.1007/BF00240672
Radiation change in normal organs: an overview of body imaging
H. Libshitz (2004)
10.1016/j.radonc.2010.02.032
The clinical characteristics and non-steroidal treatment for radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy.
E. Ogo (2010)
10.1007/978-3-642-83405-9_46
Hodgkin's disease.
D. Kaufman (1992)
10.1007/s00066-007-2002-9
Photons or Protons: Precision Radiotherapy of Lung Cancer
T. Auberger (2007)
10.1097/00043426-199911000-00025
Principles and Practice of Radiation Oncology
C. A. Pérez (1987)
10.1016/J.IJROBP.2006.01.052
Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
J. Chang (2006)
10.1164/AJRCCM.158.6.9711036
Bronchiolitis Obliterans Organizing Pneumonia Syndrome Primed by Radiation Therapy to the Breast
B. Crestani (1998)
10.1016/B978-1-4160-4048-4.50088-X
Radiation-Induced Lung Disease
J. Erasmus (2008)
10.1183/09031936.99.14613769
Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
T. Bury (1999)
10.1016/j.ijrobp.2010.04.049
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.
J. Chang (2011)
10.1038/bjc.1989.64
Continuous, hyperfractionated, accelerated radiotherapy (CHART).
S. Dische (1989)
Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P)
B. Crestani (1998)
10.1102/1470-7330.2007.0027
PET/CT and hepatic radiation injury in esophageal cancer patients
R. Iyer (2007)
10.1016/j.ijrobp.2008.10.054
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
M. Feng (2009)
10.1016/0360-3016(84)90203-7
Symptomatic radiation-induced pericarditis in Hodgkin's disease.
W. Mill (1984)
10.1002/cncr.21007
Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma
K. Rosenzweig (2005)
Non-Hodgkin's lymphoma.
A. Skarin (1989)
10.1016/J.IJROBP.2006.05.024
Design of 4D treatment planning target volumes.
E. Rietzel (2006)
10.1097/JTO.0b013e318074de34
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
H. Onishi (2007)
10.1016/0360-3016(88)90348-3
Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer.
B. Haffty (1988)
10.1016/j.clon.2010.06.013
A review of the clinical evidence for intensity-modulated radiotherapy.
J. Staffurth (2010)
10.1093/jicru_ndm021
Prescribing, Recording, and Reporting Proton-Beam Therapy
Icru (1993)
10.1016/j.radonc.2010.09.006
Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
B. Hoppe (2010)
Perez & Brady's Principles and Practice of Radiation Oncology
W. Small (2013)
Advances in Radiation Biology
J. T. Lett (1976)
10.1200/JCO.1992.10.6.890
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.
P. Warde (1992)
10.1148/RG.244035160
Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis.
Y. Choi (2004)
10.1097/00004728-198402000-00003
Radiation‐Induced Pulmonary Change: CT Findings
H. Libshitz (1984)
10.1016/S0167-8140(99)00087-0
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.
M. Saunders (1999)
Development of radiation pneumonitis. Time and dose factors.
F. L. Jennnings (1962)
10.1056/NEJM199212033272302
A meta-analysis of thoracic radiotherapy for small-cell lung cancer.
J. Pignon (1992)
10.1177/030089160509100508
Unusual Complication after Radiotherapy for Breast Cancer Bronchiolitis Obliterans Organizing Pneumonia Case Report and Review of the Literature
G. Guerriero (2005)
10.1148/rg.317115505
Role of imaging in the diagnosis, staging, and treatment of thymoma.
M. Benveniste (2011)
10.1016/j.semradonc.2010.01.005
Improving radiation conformality in the treatment of non-small cell lung cancer.
Joe Y. Chang (2010)
10.1148/RADIOGRAPHICS.20.1.G00JA0483
Radiation-induced lung disease and the impact of radiation methods on imaging features.
K. Park (2000)
10.1016/0360-3016(94)00543-5
Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results.
M. Graham (1995)
10.1007/BF02953304
Hodgkin’s Disease
J. McGrath (1964)
10.1016/S0039-6109(16)44330-6
A new international staging system for lung cancer.
C. Mountain (1986)
Biological basis of fractionation and timing of radiotherapy
DK Ruysscher (2010)
10.1016/0305-7372(89)90044-3
Radiation therapy for medically inoperable stage I and II non-small cell lung cancer.
J. Armstrong (1989)
10.1016/S0360-3016(02)04151-2
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
A. Ahamad (2003)
10.1016/B978-0-12-035405-4.50012-8
The Four R's of Radiotherapy
H. Withers (1975)
10.1016/j.radonc.2010.07.014
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques.
V. Bettinardi (2010)
10.1016/S0140-6736(73)92443-4
Treatment of oat-celled carcinoma of the bronchus.
W. Fox (1973)
Surgical therapy for carcinoma of the lung.
Shields Tw (1982)



This paper is referenced by
10.18632/oncotarget.19032
Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy.
Wenyan Pan (2017)
10.1002/ijc.32059
Modeling and multiscale characterization of the quantitative imaging based fibrosis index reveals pathophysiological, transcriptome and proteomic correlates of lung fibrosis induced by fractionated irradiation
C. Zhou (2019)
10.1080/2162402X.2015.1123366
Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis
M. Dadrich (2016)
10.1016/j.ctro.2018.10.005
Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model
C. Zhou (2019)
10.1038/s12276-019-0240-4
Blocking TBK1 alleviated radiation-induced pulmonary fibrosis and epithelial-mesenchymal transition through Akt-Erk inactivation
Hongjin Qu (2019)
10.1155/2014/251067
Expression of Interleukin-17A in Lung Tissues of Irradiated Mice and the Influence of Dexamethasone
L. Wang (2014)
10.22246/JIKM.2017.38.1.32
Preliminary Study for Development of Pattern Identification Tool for Radiation Pneumonitis
김 재효 (2017)
10.1155/2018/5109497
miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2
L. Song (2018)
10.1053/j.ro.2015.01.007
Pitfalls in oncologic imaging: complications of chemotherapy and radiotherapy in the chest.
C. Viswanathan (2015)
10.1186/S41936-019-0083-5
Recent advances in radiotherapy and its associated side effects in cancer—a review
G. Mohan (2019)
A Pseudo Non-Cartesian Pulse Sequence For Hyperpolarized Xenon-129 Gas MRI of Rodent Lungs At Low Magnetic Field Strength
Krzysztof Wawrzyn (2014)
10.2147/DDDT.S80958
Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice
Yan-Yang Wang (2015)
10.1038/gt.2016.86
Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice
D. Shin (2017)
10.1007/978-3-319-89710-3_3
The Trachea and Bronchi
M. Salvatore (2018)
10.1038/cddis.2017.372
Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation
Verena Ziegler (2017)
10.1667/RR14685.1
A Single Exposure to Low- or High-LET Radiation Induces Persistent Genomic Damage in Mouse Epithelial Cells In Vitro and in Lung Tissue
E. Werner (2017)
10.1080/09553002.2020.1683642
Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury
Matthew D. Fountain (2019)
10.1124/jpet.118.248807
Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level
Chao Zhang (2018)
10.1118/1.4960367
Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications?
F. Lan (2016)
Imaging after radiation therapy of thoracic tumors
B. Ghayea (2016)
10.3892/mmr.2019.10263
Silencing of heat shock protein 27 increases the radiosensitivity of non-small cell lung carcinoma cells
L. Xu (2019)
10.3390/antiox5030022
Protection against Radiotherapy-Induced Toxicity
S. Hall (2016)
10.1042/BSR20192795
miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164
Tao Wei (2020)
10.1053/j.sult.2018.02.002
Imaging of Radiation Treatment of Lung Cancer.
M. Benveniste (2018)
10.1371/journal.pone.0131671
Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice
S. Lee (2015)
10.1053/j.semdp.2018.03.002
Iatrogenic pulmonary lesions.
A. Roden (2018)
10.1186/s13244-020-00933-z
COVID-19 pneumonia: the great radiological mimicker
Selin Ardali Duzgun (2020)
10.1016/B978-1-4557-2532-8.00010-4
10 – Diffuse Parenchymal Lung Diseases Associated with Known Etiologic Agents
S. Weinberger (2014)
10.1016/j.tiv.2015.09.007
A novel role of long non-coding RNAs in response to X-ray irradiation.
Jihua Nie (2015)
10.1016/j.canlet.2015.08.011
NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.
N. Duru (2015)
10.1016/J.JRADIO.2016.07.008
Imagerie après radiothérapie de tumeurs thoraciques
B. Ghaye (2016)
10.3390/ijms18122525
Synthetic Secoisolariciresinol Diglucoside (LGM2605) Protects Human Lung in an Ex Vivo Model of Proton Radiation Damage
A. Velalopoulou (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar